Document type
ArticleVersion
Published versionPublication date
Publication license
Please use this identifier to cite or link to this item: https://hdl.handle.net/2445/204202
Differential DNA damage repair and PARP inhibitor vulnerability of the mammary epithelial lineages
Journal Title
Director/Tutor
Journal ISSN
Volume Title
Related resource
Abstract
It is widely assumed that all normal somatic cells can equally perform homologous recombination (HR) and non-homologous end joining in the DNA damage response (DDR). Here, we show that the DDR in normal mammary gland inherently depends on the epithelial cell lineage identity. Bioinformatics, post-irradiation DNA damage repair kinetics, and clonogenic assays demonstrated luminal lineage exhibiting a more pronounced DDR and HR repair compared to the basal lineage. Consequently, basal progenitors were far more sensitive to poly(ADP-ribose) polymerase inhibitors (PARPis) in both mouse and human mammary epithelium. Furthermore, PARPi sensitivity of murine and human breast cancer cell lines as well as patient derived xenografts correlated with their molecular resemblance to the mammary progenitor lineages. Thus, mammary epithelial cells are intrinsically divergent in their DNA damage repair capacity and PARPi vulnerability, potentially influencing the clinical utility of this targeted therapy.
Subject
Subject (English)
Citation
Citation
KIM, Hyeyeon, et al. Differential DNA damage repair and PARP inhibitor vulnerability of the mammary epithelial lineages. Cell Reports. 2023. Vol. 42, num. 10. ISSN 2211-1247. [consulted: 17 of June of 2026]. Available at: https://hdl.handle.net/2445/204202